Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
UniQure Hemophilia Therapy Placed on FDA Clinical Hold
By Dan Weil
Dec 21, 2020 10:18 AM EST
INVESTING
UniQure Hemophilia Therapy Placed on FDA Clinical Hold
By Dan Weil
Dec 21, 2020 10:18 AM EST
PRESS RELEASES
CSL Behring Agrees To Acquire Novel Late-Stage Gene Therapy Candidate For Hemophilia B Patients From UniQure
By PR Newswire
Jun 24, 2020 6:28 PM EDT
MARKETS
UniQure Jumps on Report It's Exploring a Possible Sale
By Joseph Woelfel
Jun 17, 2019 9:33 AM EDT
INVESTING
3 Cutting-Edge Biotech Stocks That Can Double in Value
By Tip Ranks
May 14, 2018 7:00 AM EDT
MARKETS
Markets Keep Eye on China Presidential Speech; Biotechs Bounce -- ICYMI
By Michael Brown
Apr 9, 2018 8:00 PM EDT
STOCKS
7 Winners and Losers From Biggest Biotech Conference of 2017
By Tony Owusu
Dec 13, 2017 11:34 AM EST
HEALTH
Biotech Movers: Arena Shares Skyrocket on Positive Data for Ralinepag
By Armie Margaret Lee
Jul 11, 2017 8:39 PM EDT
STOCKS
5 stocks setting up for big breakouts
By Roberto Pedone
Jan 6, 2017 2:33 PM EST
STOCKS
Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
By Adam Feuerstein
Dec 5, 2016 1:11 PM EST
STOCKS
Spark's hemophilia gene therapy remains effective despite immune reactions
By Adam Feuerstein
Dec 3, 2016 1:04 PM EST
OPINION
8 stocks under $10 to trade for huge profits
By Roberto Pedone
Jul 29, 2016 6:59 AM EDT
MARKETS
Trade-Ideas: UniQure (QURE) Is Today's Weak On High Relative Volume Stock
By TheStreet Wire
Jun 14, 2016 10:19 AM EDT
JIM CRAMER
'Mad Money' Lightning Round: Take the money and run from Sprint
By Scott Rutt
Jan 28, 2016 6:00 AM EST
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: More pain ahead, thanks to the Fed
By Scott Rutt
Jan 27, 2016 8:20 PM EST
MARKETS
UniQure (QURE) Weak On High Volume Today
By TheStreet Wire
Jan 11, 2016 10:01 AM EST
OPINION
Buy these five breakout stocks now for big gains.
By Roberto Pedone
Jan 8, 2016 8:40 AM EST
MARKETS
UniQure (QURE) Weak On High Volume Today
By TheStreet Wire
Nov 30, 2015 10:13 AM EST
INVESTING
Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
By The Fly Staff
Oct 5, 2015 10:53 AM EDT
MARKETS
UniQure (QURE) Marked As A Dead Cat Bounce Stock
By TheStreet Wire
Sep 30, 2015 9:46 AM EDT
MARKETS
Today's Dead Cat Bounce Stock: UniQure (QURE)
By TheStreet Wire
Sep 22, 2015 10:01 AM EDT
MARKETS
UniQure (QURE) Trading With Heavy Volume Before Market Open
By TheStreet Wire
Sep 21, 2015 8:27 AM EDT
MARKETS
UniQure (QURE) Is Today's Strong On High Volume Stock
By TheStreet Wire
Sep 18, 2015 10:00 AM EDT
STOCKS
Biotech Stocks Get Burned This Summer, but Fall Might Bring Relief
By Adam Feuerstein
Aug 19, 2015 10:30 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
By Chris Sahl
Aug 4, 2015 8:40 PM EDT